e-Therapeutics appoints Daniel Elger as CFO
This article was originally published in Scrip
Dr Daniel Elger has joined e-Therapeutics, a network pharmacology company focused on drug discovery and development, as chief financial officer. Dr Elger was previously vice-president of marketing and communications at cancer drug developer Antisoma. He joins as John Cordiner, the company's finance director, has resigned to pursue other business interests.